SALL4 and cholangiocarcinoma: In contrast, mice lacking Sall4 in the AY-CCA exhibited a robust reduction in gross tumor burden, evidenced by a significantly lower LW/BW ratio and diminished macroscopic tumor growth compared with Sall4 WTGFP (Fig. 1C and D).